Manipis Kathleen, Cronin Paula, Street Deborah, Church Jody, Viney Rosalie, Goodall Stephen
Centre for Health Economics Research and Evaluation, University of Technology Sydney, PO Box 123, Broadway, NSW, 2007, Australia.
Pharmacoeconomics. 2025 Apr;43(4):453-467. doi: 10.1007/s40273-024-01458-9. Epub 2025 Jan 4.
Cost-utility analyses commonly use two primary methods to value productivity: the human capital approach (HCA) and the friction cost approach (FCA). Another less frequently used method is the willingness-to-pay (WTP) approach, which estimates the monetary value individuals assign to avoiding an illness. In the context of foodborne illnesses (FBI), productivity loss represents one of the most significant economic impacts, particularly in developed nations. These losses arise from factors such as missed workdays, reduced workplace efficiency due to illness, and long-term health complications that can limit an individual's ability to work. As a result, accurately quantifying productivity loss is critical in understanding the broader economic burden of FBI.
Our aim was to compare the impact of valuation methods used to measure productivity loss in an economic evaluation, using a hypothetical intervention for FBI caused by campylobacter as a case study. Cost effectiveness from three perspectives is examined: health care system, employee, and employer.
A Markov model with a 10-year time horizon was developed to evaluate the morbidity and productivity impacts of FBI caused by campylobacter. The model included four health states: 'healthy', 'acute gastroenteritis', 'irritable bowel syndrome and being unable to work some of the time', and 'irritable bowel syndrome and unable to work'. Five approaches to valuing productivity loss were compared: model 1 (cost-utility analysis), model 2 (HCA), model 3 (FCA), model 4 (FCA+WTP to avoid illness with paid sick leave), and model 5 (WTP to avoid illness without paid sick leave). Health outcomes and costs were discounted using a 5% discount rate. Costs were reported in 2024 Australian dollars ($AUD).
Model 1, which did not include productivity losses, yielded the highest incremental cost-effectiveness ratio (ICER) at $56,467 per quality-adjusted life-year (QALY) gained. The inclusion of productivity costs (models 2-5) significantly increased the total costs in both arms of the models but led to a marked reduction in the ICERs. For example, model 2 (HCA) resulted in an ICER of $11,174/QALY gained, whereas model 3 (FCA) resulted in $21,136/QALY gained. Models 4 and 5, which included WTP approaches, had ICERs of $19,661/QALY gained and $24,773/QALY gained, respectively.
These findings underscore the significant impact of different modelling approaches to productivity loss on ICER estimates and consequently the decision to adopt a new policy or intervention. The choice of perspective in the analysis is critical, as it determines how the short-term and long-term productivity losses are accounted for and valued. This highlights the importance of carefully selecting and justifying the perspective and valuation methods used in economic evaluations to ensure informed and balanced policy decisions.
成本效用分析通常使用两种主要方法来评估生产力:人力资本法(HCA)和摩擦成本法(FCA)。另一种较少使用的方法是支付意愿(WTP)法,该方法估计个人为避免患病而赋予的货币价值。在食源性疾病(FBI)的背景下,生产力损失是最重大的经济影响之一,尤其是在发达国家。这些损失源于诸如工作日缺勤、因病导致的工作场所效率降低以及可能限制个人工作能力的长期健康并发症等因素。因此,准确量化生产力损失对于理解FBI更广泛的经济负担至关重要。
我们的目的是通过将针对弯曲杆菌引起的FBI的假设干预作为案例研究,比较在经济评估中用于衡量生产力损失的估值方法的影响。从三个角度考察成本效益:医疗保健系统、员工和雇主。
开发了一个为期10年的马尔可夫模型,以评估弯曲杆菌引起的FBI的发病率和生产力影响。该模型包括四种健康状态:“健康”、“急性肠胃炎”、“肠易激综合征且有时无法工作”以及“肠易激综合征且无法工作”。比较了五种评估生产力损失的方法:模型1(成本效用分析)、模型2(HCA)、模型3(FCA)、模型4(FCA + 为避免患病而支付病假工资的WTP)和模型5(为避免患病而不支付病假工资的WTP)。使用5%的贴现率对健康结果和成本进行贴现。成本以2024澳元($AUD)报告。
不包括生产力损失的模型1产生了最高的增量成本效益比(ICER),每获得一个质量调整生命年(QALY)为56,467澳元。纳入生产力成本(模型2 - 5)显著增加了模型两方面的总成本,但导致ICER显著降低。例如,模型2(HCA)每获得一个QALY的ICER为11,174澳元,而模型3(FCA)为21,136澳元。包括WTP方法的模型4和模型5每获得一个QALY的ICER分别为19,661澳元和24,773澳元。
这些发现强调了不同的生产力损失建模方法对ICER估计以及因此对采用新政策或干预措施的决策的重大影响。分析中视角的选择至关重要,因为它决定了如何核算和评估短期和长期的生产力损失。这突出了在经济评估中仔细选择并说明所使用的视角和估值方法的重要性,以确保做出明智和平衡的政策决策。